Parmeliaceae family: Phytochemistry, pharmacological potential and phylogenetic features

RSC Advances

Volumn 4, Issue 103, 2014, Pages 59017-59047

  Gómez Serranillos, M Pilar ^a   Fernández Moriano, Carlos ^a   González Burgos, Elena ^a   Divakar, Pradeep Kumar ^a   Crespo, Ana ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; BIOLOGY; BIOMOLECULES; FUNGI; KETONES; MICROORGANISMS;

ANTI-INFLAMMATORIES; ANTIOXIDANT POTENTIAL; BIOACTIVE COMPOUNDS; HETEROGENEOUS DISTRIBUTIONS; ISOLATED COMPOUNDS; METABOLITE CONTENT; PHARMACOLOGICAL ACTIVITY; SECONDARY METABOLITES;

METABOLITES;

EID: 84911488133     PISSN: None     EISSN: 20462069     Source Type: Journal    
DOI: 10.1039/c4ra09104c     Document Type: Review

References (178)

1. D. L. Hawksworth and R. Honegger, The lichen thallus: A symbiotic phenotype of nutritionally specialized fungi and its response to gall producers, in Plant galls: Organisms, interactions, populations, ed. M. A. J. Williams, 1994, Clarendon Press, Oxford, UK, pp. 77-98.
2. A. Crespo, P. K. Divakar and D. L. Hawksworth, Generic concepts in parmelioid lichens, and the phylogenetic value of characters used in their circumscription, Lichenologist, 2011, 43, 511-535.
3. A. Thell, A. Crespo, P. K. Divakar, I. Kärnefelt, S. D. Leavitt, H. T. Lumbsch and M. R. Seaward, A review of the lichen family Parmeliaceae - history, phylogeny and current taxonomy, Nord. J. Bot., 2012, 30, 641-664.
4. C. Linnaeus, Species plantarum. Holmiae, 1753.
5. J. A. Elix, Progress in the generic delimitation of Parmelia sensu lato lichens (Ascomycotina, Parmeliaceae), Bryologist, 1993, 96, 359-383.
6. A. Crespo and S. Perez-Ortega, Cryptic species and species pairs in lichens, Anales del Jardin Botanico de Madrid, 2009, 66, 71-81.
7. C. Printzen, Lichen systematics: the role of morphological and molecular data to reconstruct phylogenetic relationships, Prog. Bot., 2010, 71, 233-275.
8. H. T. Lumbsch and S. D. Leavitt, Goodbye morphology? A paradigm shift in the delimitation of species in lichenized fungi, Fungal Divers., 2011, 50, 59-72.
9. G. Shrestha and L. L. S. Clair, Lichens: a promising source of antibiotic and anticancer drugs, Phytochem. Rev., 2013, 12, 229-244.
10. S. Huneck, The significance of lichen and their metabolites, Naturwissenschaften, 2013, 86, 559-570.
11. K. S. Masters and S. Bräse, Xanthones from fungi, lichens, and bacteria: the natural products and their synthesis, Chem. Rev., 2012, 112, 3717-3776.
12. S. Huneck and I. Yoshimura, Identification of Lichen Substances, Springer, Berlin, Heidelberg, 1996.
13. S. Huneck, Progress in the Chemistry of Organic Natural Products, Springer, Heidelberg, New York, 2001, vol. 81.
14. D. Fahselt, Secondary biochemistry of lichens, Symbiosis, 1994, 16, 117-165.
15. I. Schmitt, M. P. Martin, S. Kautz and H. T. Lumbsch, Diversity of non-reducing polyketide synthase genes in the Pertusariales (lichenized Ascomycota): A phylogenetic perspective, Phytochemistry, 2005, 66, 1241-1253.
16. J. C. Frisvad, B. Andersen and U. Thrane, The use of secondary metabolite profiling in chemotaxonomy of filamentous fungi, Mycol. Res., 2008, 112, 231-240.
17. A. Crespo, F. Kauff, P. K. Divakar, R. del Prado, S. Pérez-Ortega, G. Amo de Paz, Z. Ferencova, O. Blanco, B. Roca-Valiente and J. Núñez-Zapata, et al. Phylogenetic generic classification of parmelioid lichens (Parmeliaceae, Ascomycota) based on molecular, morphological and chemical evidence, Taxon, 2010, 59, 1735-1753.
18. P. K. Divakar, F. Kauff, A. Crespo, S. D. Leavitt and H. T. Lumbsch, Understanding phenotypical character evolution in parmelioid lichenized fungi (Parmeliaceae, Ascomycota), PLoS One, 2013, 8, e83115.
19. V. Karunaratne, K. Bombuwela, S. Kathirgamanathar and V. M. Thadhani, Lichens: A chemically important biota, J. Natl. Sci. Found. Sri Lanka, 2005, 33, 169-186.
20. I. Oksanen, Ecological and biotechnological aspects of lichens, Appl. Microbiol. Biotechnol., 2006, 73, 723-734.
21. G. A. Llano, Economic uses of lichens, Econ. Bot., 1948, 2, 26.
22. D. H. S. Richardson, Medicinal and other economic aspects of lichens, in CRC Handbook of Lichenology, ed. M. Galun, CRC Press, Boca Raton, 1988, vol. 3, pp. 93-108.
23. M. R. Gonzalez-Tejero, M. J. Martinez-Lirola, M. Casares-Porcel and J. Molero-Mesa, Three lichens used in popular medicine in Eastern Andalucia, Econ Bot, Spain, 1995, 49, pp. 96-98.
24. D. K. Upreti, P. K. Divakar and S. Nayaka, Commercial and ethnic use of lichens in India, Econ. Bot., 2005, 59, 269-273.
25. K. Ingolfsdottir, M. A. Hjalmarsdottir, A. Sigurdsson, G. A. Gudjonsdottir, A. Brynjolfsdottir and O. Steingrimsson, In vitro susceptibility of Helicobacter pylori to protolichesterinic acid from the lichen Cetraria islandica, Antimicrob. Agents Chemother., 1997, 41, 215-217.
26. Y. Bayir, F. Odabasoglu, A. Cakir, A. Aslan, H. Suleyman, M. Halici and C. Kazaz, The inhibition of gastric mucosal lesion, oxidative stress and neutrophil-infiltration in rats by the lichen constituent diffractaic acid, Phytomedicine, 2006, 13, 584-590.
27. M. Candan, M. Yilmaz, T. Tay, M. Kivanc¸ and H. Türk, Antimicrobial activity of extracts of the lichen Xanthoparmelia pokornyi and its gyrophoric and stenosporic acid constituents, Z. Naturforsch., C: J. Biosci., 2006, 61, 319-323.
28. M. Bačkorová, M. Bačkor, J. Mikeš, R. Jendželovský and P. Fedoročko, Variable responses of different human cancer cells to the lichen compounds parietin, atranorin, usnic acid and gyrophoric acid, Toxicol. in vitro, 2011, 25, 37-44.
29. J. Bebert, Sur une nouvelle substance découverte dans le lichen vulpi-nus, J. Pharm. Sci., 1831, 17, 696-700.
30. W. Knop, Chemisch-physiologische Untersuchung uber die Flechten, Justus Lieb. Ann. Chem., 1844, 49, 103-124.
31. M. Kosanić, N. Manojlović, S. Janković, T. Stanojković and B. Ranković, Evernia prunastri and Pseudoevernia furfuraceae lichens and their major metabolites as antioxidant, antimicrobial and anticancer agents, Food Chem. Toxicol., 2013, 53, 112-118.
32. K. Molnar and E. Farkas, Current Results on Biological activities of Lichen Secondary metabolites: A Review, Z. Naturforsch., C: J. Biosci., 2010, 65c, 157-173.
33. A. H. Wei, D. N. Zhou, J. L. Ruan, Y. L. Cai, C. M. Xiong and M. X. Li, Characterisation of phenols and antioxidant and hypolipidaemic activities of Lethariella cladonioides, J. Sci. Food Agric., 2012, 92, 373-379.
34. M. Cocchietto, N. Skert, P. L. Nimis and G. Sava, A review on usnic acid, an interesting natural compound, Naturwissenschaften, 2002, 89, 137-146.
35. K. Ingólfsdóttir, Usnic acid, Phytochemistry, 2002, 61, 729-736.
36. M. M. Kosanić, B. R. Ranković and T. P. Stanojković, Antioxidant, antimicrobial and anticancer activities of three Parmelia species, J. Sci. Food Agric., 2012, 92, 1909-1916.
37. N. Manojlović, B. Ranković, M. Kosanić, P. Vasiljević and T. Stanojković, Chemical composition of three Parmelia lichens and antioxidant, antimicrobial and cytotoxic activities of some their major metabolites, Phytomedicine, 2012, 19, 1166-1172.
38. B. C. Behera, N. Verma, A. Sonone and U. Makhija, Antioxidant and antibacterial activities of lichen Usnea ghattensis in vitro, Biotechnol. Lett., 2005, 27, 991-995.
39. M. Güllüce, A. Aslan, M. Sokmen, F. Sahin, A. Adiguzel, G. Agar and A. Sokmen, Screening the antioxidant and antimicrobial properties of the lichens Parmelia saxatilis, Platismatia glauca, Ramalina pollinaria, Ramalina polymorpha and Umbilicaria nylanderiana, Phytomedicine, 2006, 13, 515-521.
40. B. Ranković, D. Ranković and D. Marić, Antioxidant and antimicrobial activity of some lichen species, Microbiology, 2010, 79, 809-815.
41. P. Srivastava, D. K. Upreti, T. N. Dhole, A. K. Srivastava and M. T. Nayak, Antimicrobial Property of Extracts of Indian Lichen against Human Pathogenic Bacteria, Interdiscip. Perspect. Infect. Dis., 2013, 709348.
42. B. Ranković, M. Misić and S. Sukdolak, The antimicrobial activity of substances derived from the lichens Physcia aipolia, Umbilicaria polyphylla, Parmelia caperata and Hypogymnia physodes, World J. Microbiol. Biotechnol., 2008, 24, 1239-1242.
43. B. Ranković, D. Ranković, M. Kosanić and D. Maric, Antioxidant and antimicrobial properties of the lichens Anaptychya ciliaris, Nephroma parile, Ochrolechia tartarea and Parmelia centrifuga, Cent. Eur. J. Biol., 2010, 5, 649-655.
44. B. Ranković, M. Misić and S. Sukdolak, Evaluation of antimicrobial activity of the lichens Lasallia pustulata, Parmelia sulcata, Umbilicaria crustulosa, and Umbilicaria cylindrica, Microbiology, 2007, 76, 723-727.
45. R. Chauhan and J. Abraham, In vitro antimicrobial potential of the lichen Parmotrema sp. extracts against various pathogens, Iran. J. Basic Med. Sci., 2013, 16, 882-885.
46. T. Mitrović, S. Stamenković, V. Cvetković, S. Tošić, M. Stanković, I. Radojević, O. Stefanović, L. Comić, D. Dačić, M. Curčić and S. Marković, Antioxidant, antimicrobial and antiproliferative activities of five lichen species, Int. J. Mol. Sci., 2011, 12, 5428-5448.
47. B. Paudel, H. Datta Bhattarai, D. Prasad Pandey, J. Seoun Hur, S. Gyu Hong, I. C. Kim and J. Han Yim, Antioxidant, antibacterial activity and brine shrimp toxicity test of some mountainous lichens from Nepal, Biol. Res., 2012, 45, 387-391.
48. D. Cansaran Duman, D. Kahya, E. Yurdakulola and O. Atakol, Identification and quantitation of usnic acid from the lichen Usnea species of Anatolia and antimicrobial activity, Z. Naturforsch., C: J. Biosci., 2006, 61, 773-776.
49. V. K. Gupta, S. Verma, S. Gupta, A. Singh, A. Pal, S. K. Srivastava, P. K. Srivastava, S. C. Singh and M. P. Darokar, Membrane-damaging potential of natural L-(-)-usnic acid in Staphylococcus aureus, Eur. J. Clin. Microbiol. Infect. Dis., 2012, 31, 3375-3383.
50. M. Candan, M. Yilmaz, T. Tay, M. Erdem and A. O. Türk, Antimicrobial activity of extracts of the lichen Parmelia sulcata and its salazinic acid constituent, Z. Naturforsch., C: J. Biosci., 2007, 62, 619-621.
51. A. O. Türk, M. Yilmaz, M. Kivanc¸ and H. Türk, The antimicrobial activity of extracts of the lichen Cetraria aculeata and its protolichesterinic acid constituent, Z. Naturforsch., C: J. Biosci., 2003, 58, 850-854.
52. M. Kosanić and B. Ranković, Lichens as possible sources of antioxidants, Pak. J. Pharm. Sci., 2001, 24, 165-170.
53. J. Boustie, S. Tomasi and M. Grube, Bioactive lichen metabolites: alpine habitats as an untapped source, Phytochem. Rev., 2011, 10, 287-307.
54. S. M. Singh, P. Singh and R. Ravindra, Screening of antioxidant potential of Arctic lichens, Polar Biol., 2011, 34, 1775-1782.
55. B. Ranković, M. Kosanić, T. Stanojković, P. Vasiljević and N. Manojlović, Biological Activities of Toninia candida and Usnea barbata together with Their Norstictic Acid and Usnic Acid Constituents, Int. J. Mol. Sci., 2012, 13, 14707-14722.
56. V. P. Zambare and L. P. Christopher, Biopharmaceutical potential of lichens, Pharm Biol., 2012, 50, 778-798.
57. E. Kotan, L. Alpsoy, M. Anar, A. Aslan and G. Agar, Protective role of methanol extract of Cetraria islandica (L.) against oxidative stress and genotoxic effects of AFB1 in human lymphocytes in vitro, Toxicol. Ind. Health, 2011, 27, 599-605.
58. I. Gülc¸in, M. Oktay, O. I. Küfrevioʇlu and A. Aslan, Determination of antioxidant activity of lichen Cetraria islandica (L) Ach, J. Ethnopharmacol., 2002, 79, 325-329.
59. G. Stojanović, I. Stojanović, V. Stankov-Jovanović, V. Mitić and D. Kostić, Reducing power and radical scavenging activity of four Parmeliaceae species, Cent. Eur. J. Biol., 2010, 5, 808-813.
60. M. Kosanić, B. Ranković and J. Vukojević, Antioxidant properties of some lichen species, J. Food Sci. Technol., 2011, 48, 584-590.
61. K. Kinoshita, T. Togawa, A. Hiraishi, Y. Nakajima, K. Koyama, T. Narui, L. S. Wang and K. Takahashi, Antioxidant activity of red pigments from the lichens Lethariella sernanderi, L. cashmeriana, and L. sinensis, J. Nat. Med., 2010, 64, 85-88.
62. S. V. Praveen Kumar, T. R. Prashith Kekuda, K. S. Vinayaka, S. J. Sudharshan, N. Mallikarjun and D. Swathi, Studies on Antibacterial, Anthelmintic and Antioxidant activities of a Macrolichen Parmotrema pseudotinctorum (des. Abb.) Hale (Parmeliaceae) from Bhadra wildlife sanctuary, Karnataka, Int. J. Pharm. Tech. Res., 2010, 2, 1207-1214.
63. N. Valencia-Islas, A. Zambrano and J. L. Rojas, Ozone reactivity and free radical scavenging behavior of phenolic secondary metabolites in lichens exposed to chronic oxidant air pollution from Mexico City, J. Chem. Ecol., 2007, 33, 1619-1634.
64. S. Ceker, F. Orhan, H. E. Kizil, L. Alpsoy, M. Gulluce, A. Aslan and G. Agar, Genotoxic and antigenotoxic potentials of two Usnea species, Toxicol. Ind. Health, 2013, DOI: 10.1177/0748233713485889.
65. B. C. Behera, N. Mahadik and M. Morey, Antioxidative and cardiovascular-protective activities of metabolite usnic acid and psoromic acid produced by lichen species Usnea complanata under submerged fermentation, Pharm. Biol., 2012, 50, 968-979.
66. B. C. Behera, N. Verma, A. Sonone and U. Makhija, Evaluation of antioxidant potential of the cultured mycobiont of a lichen Usnea ghattensis, Phytother. Res., 2005, 19, 58-64.
67. N. Verma, B. C. Behera and U. Makhija, Antioxidant and hepatoprotective activity of a lichen Usnea ghattensis in vitro, Appl. Biochem. Biotechnol., 2008, 151, 167-181.
68. F. Odabasoglu, A. Aslan, A. Cakir, H. Suleyman, Y. Karagoz, M. Halici and Y. Bayir, Comparison of antioxidant activity and phenolic content of three lichen species, Phytother. Res., 2004, 18, 938-941.
69. G. Agar, A. Aslan, E. K. Sarioglu, L. Alpsoy and S. Çeker, Protective activity of the methanol extract of Usnea longissima against oxidative damage and genotoxicity caused by aflatoxin B1 in vitro, Turk. J. Med. Sci., 2011, 41, 1043-1049.
70. M. Halici, F. Odabasoglu, H. Suleyman, A. Cakir, A. Aslan and Y. Bayir, Effects of water extract of Usnea longissima on antioxidant enzyme activity and mucosal damage caused by indomethacin in rats, Phytomedicine, 2005, 12, 656-662.
71. G. A. De Paz, J. Raggio, M. P. Gómez-Serranillos, O. M. Palomino, E. González-Burgos, M. E. Carretero and A. Crespo, HPLC isolation of antioxidant constituents from Xanthoparmelia spp, J. Pharm. Biomed. Anal., 2010, 53, 165-171.
72. S. Shibata, Y. Nishikawa, M. Tanaka, F. Fukuoka and M. Nakanishi, Antitumour activities of lichen polysaccharides, J. Cancer Res. Clin. Oncol., 1968, 71, 102-104.
73. D. E. Williams, F. Loganzo, L. Whitney, J. Togias, R. Harrison, M. P. Singh, L. A. McDonald, S. Kathirgamanathar, V. Karunaratne and R. J. Andersen, Depsides isolated from the Sri Lankan lichen Parmotrema sp. exhibit selective Plk1 inhibitory activity, Pharm. Biol., 2011, 49, 296-301.
74. Y. Yamamoto, Y. Miura, Y. Kinoshita, M. Higuchi, Y. Yamada, A. Murakami, H. Ohigashi and K. Koshimizu, Screening of tissue cultures and thalli of lichens and some of their active constituents for inhibition of tumor promoter-induced Epstein-Barr Virus activation, Chem. Pharm. Bull., 1995, 43, 1388-1390.
75. K. Ingólfsdóttir, S. Kook Lee, K. P. Bhat, K. Lee, H. B. Chai, H. Kristinsson, L. L. Song, J. Gills, J. T. Gudmundsdóttir, E. Mata-Greenwood, M. S. Jang and J. M. Pezzuto, Evaluation of selected lichens from iceland for cancer chemopreventive and cytotoxic activity, Pharm. Biol., 2000, 38, 313-317.
76. F. Ari, S. Celikler, S. Oran, N. Balikci, S. Ozturk, M. Z. Ozel, D. Ozyurt and E. Ulukaya, Genotoxic, cytotoxic, and apoptotic effects of Hypogymnia physodes (L.) Nyl. on breast cancer cells, Environ. Toxicol., 2014, 29, 804-813.
77. I. Z. Stojanović, M. Stanković, O. Jovanović, G. Petrović, A. Smelcerović and G. S. Stojanović, Effect of Hypogymnia physodes extracts and their depsidones on micronucleus distribution in human lymphocytes, Nat. Prod. Commun., 2013, 8, 109-112.
78. F. Geyikoglu, H. Turkez and A. Aslan, The protective roles of some lichen species on colloidal bismuth subcitrate genotoxicity, Toxicol. Ind. Health, 2007, 23, 487-492.
79. V. Ivanova, M. Backor, H. M. Dahse and U. Graefe, Molecular structural studies of lichen substances with antimicrobial, antiproliferative, and cytotoxic effects from Parmelia subrudecta, Prep. Biochem. Biotechnol., 2010, 40, 377-388.
80. L. F. Brandão, G. B. Alcantara, F. Matos Mde, D. Bogo, S. Freitas Ddos, N. M. Oyama and N. K. Honda, Cytotoxic evaluation of phenolic compounds from lichens against melanoma cells, Chem. Pharm. Bull., 2013, 61, 176-183.
81. K. Ingolfsdottir, W. Breu, S. Huneck, G. A. Gudjonsdottir, B. Müller-Jakic and H. Wagner, In vitro inhibition of 5-lipoxygenase by protolichesterinic acid from Cetraria islandica, Phytomedicine, 1994, 1, 187-191.
82. T. S. Bugni, C. D. Andjelic, A. R. Pole, P. Rai, C. M. Ireland and L. R. Barrows, Biologically active components of a Papua New Guinea analgesic and anti-inflammatory lichen preparation, Fitoterapia, 2009, 80, 270-273.
83. S. K. Oettl, J. Gerstmeier, S. Y. Khan, K. Wiechmann, J. Bauer, A. G. Atanasov, C. Malainer, E. M. Awad, P. Uhrin, E. H. Heiss, B. Waltenberger, D. Remias, J. M. Breuss, J. Boustie, V. M. Dirsch, H. Stuppner, O. Werz and J. M. Rollinger, Imbricaric Acid and Perlatolic Acid: Multi-Targeting Anti-Inflammatory Depsides from Cetrelia monachorum, PLoS One, 2013, 8, e76929.
84. C. Kempe, H. Grüning, N. Stasche and K. Hörmann, Icelandic moss lozenges in the prevention or treatment of oral mucosa irritation and dried out throat mucosa, Laryngol., Rhinol., Otol., 1997, 76, 186-188.
85. J. Freysdottir, S. Omarsdottir, K. Ingólfsdóttir, A. Vikingsson and E. S. Olafsdottir, In vitro and in vivo immunomodulating effects of traditionally prepared extract and purified compounds from Cetraria islandica, Int. Immunopharmacol., 2008, 8, 423-430.
86. A. Güvenc¸, E. Küpeli Akkol, I. Süntar, H. Keleş, S. Yildiz and I. Caliş, Biological activities of Pseudevernia furfuracea (L.) Zopf extracts and isolation of the active compounds, J. Ethnopharmacol., 2012, 144, 726-734.
87. K. Engel, U. Schmidt, J. Reuter, S. Weckesser, B. Simon-Haarhaus and C. M. Schempp, Usnea barbata extract prevents ultraviolet-B induced prostaglandin E2 synthesis and COX-2 expression in HaCaT keratinocytes, J. Photochem. Photobiol., B, 2007, 89, 9-14.
88. J. Q. Jin, C. Q. Li and L. C. He, Down-regulatory effect of usnic acid on nuclear factor-kappaB-dependent tumor necrosis factor-alpha and inducible nitric oxide synthase expression in lipopolysaccharide-stimulated macrophages RAW 264.7, Phytother. Res., 2008, 22, 1605-1609.
89. K. C. Kumar and K. Müller, Lichen metabolites. 1. Inhibitory action against leukotriene B4 biosynthesis by a non-redox mechanism, J. Nat. Prod., 1999, 62, 817-820.
90. M. I. Choudhary, Azizuddin, S. Jalil and A.-U. Rahman, Bioactive phenolic compounds from a medicinal lichen, Usnea longissima, Phytochemistry, 2005, 66, 2346-2350.
91. K. A. Lee and M. S. Kim, Glucosidase inhibitor from Umbilicaria esculenta, Can. J. Microbiol., 2000, 46, 1077-1081.
92. S. B. Patil, V. A. Ghadyale, S. S. Taklikar, C. R. Kulkarni and A. U. Arvindekar, Insulin secretagogue, alpha-glucosidase and antioxidant activity of some selected spices in streptozotocin-induced diabetic rats, Plant Foods Hum. Nutr., 2011, 66, 85-90.
93. N. Verma, B. C. Behera, A. Sonone and U. Makhija, Lipid peroxidation and tyrosinase inhibition by lichen symbionts grown in vitro, Afr. J. Biochem. Res., 2008, 2, 225-231.
94. M. S. Kim and H. B. Cho, Melanogenesis inhibitory effects of methanolic extracts of Umbilicaria esculenta and Usnea longissima, J. Microbiol., 2007, 45, 578-582.
95. B. Cheng, S. Cao, V. Vasquez, T. Annamalai, G. Tamayo-Castillo, J. Clardy and Y. C. Tse-Dinh, Identification of anziaic acid, a lichen depside from Hypotrachyna sp., as a new topoisomerase poison inhibitor, PLoS One, 2013, 8, e60770.
96. F. Bucar, I. Schneider, H. Ogmundsdóttir and K. Ingólfsdóttir, Anti-proliferative lichen compounds with inhibitory activity on 12(S)-HETE production in human platelets, Phytomedicine, 2004, 11, 602-606.
97. J. H. Sung, J. W. Chon, M. A. Lee, J. K. Park, J. T. Woo and Y. K. Park, The anti-obesity e ffect of Lethariella cladonioides in 3T3-L1 cells and obese mice, Nutr. Res. Pract., 2011, 5, 503-510.
98. C. M. Rathnayake, A. P. Malalasekera, R. P. Perera and W. D. Ratnasooriya, Hypoglycemic activity of methanol and methylene chloride extracts of the lichen Parmotrema grayana, Inventi Impact: Ethnopharmacol., 2010, 2, Inventi:ep/128/10.
99. S. Colak, F. Geyikoglu, H. Türkez, T. Bakir and A. Aslan, The ameliorative e ffect of Cetraria islandica against diabetes-induced genetic and oxidative damage in human blood, Pharm. Biol., 2013, 51, 1531-1537.
100. G. Y. Deniz, F. Geyikoglu, H. Türkez, T. O. Bakir, S. Colak and A. Aslan, The biochemical and histological effects of lichens in normal and diabetic rats, Toxicol. Ind. Health, 2013, DOI: 10.1177/0748233713506769.
101. F. Odabasoglu, A. Cakir, H. Suleyman, A. Aslan, Y. Bayir, M. Halici and C. Kazaz, Gastroprotective and antioxidant effects of usnic acid on indomethacin-induced gastric ulcer in rats, J. Ethnopharmacol., 2006, 103, 59-65.
102. K. A. Lee and M. S. Kim, Antiplatelet and antithrombotic activities of methanol extract of Usnea longissima, Phytother. Res., 2005, 19, 1061-1064.
103. A. Crespo and O. F. Cubero, A molecular approach to the circumscription and evaluation of some genera segregated from Parmelia s.l, Lichenologist, 1998, 30, 369-380.
104. J. E. Mattsson and M. Wedin, Phylogeny of the Parmeliaceae - DNA data versus morphological data, Lichenologist, 1998, 30, 463-472.
105. P. K. Divakar, A. Crespo, O. Blanco and H. T. Lumbsch, Phylogenetic significance of morphological characters in the tropical Hypotrachyna clade of parmelioid lichens (Parmeliaceae, Ascomycota), Mol. Phylogenet. Evol., 2006, 40, 448-458.
106. G. De Paz, P. Cubas, P. K. Divakar, H. T. Lumbsch and A. Crespo, Origin and diversification of major clades in parmelioid lichens (Parmeliaceae, Ascomycota) during the Paleogene inferred by Bayesian analysis, PLoS One, 2011, 6, e28161.
107. P. K. Divakar, R. Del-Prado, H. T. Lumbsch, M. Wedin, T. L. Esslinger and S. D. Leavitt, Diversification of the newly recognized lichen-forming fungal lineage Montanelia (Parmeliaceae, Ascomycota) and its relation to key geological and climatic events, Am. J. Bot., 2012, 99, 2014-2026.
108. S. D. Leavitt, T. L. Esslinger, T. Spribille, P. K. Divakar and H. T. Lumbsch, Multilocus phylogeny of the lichen-forming fungal genus Melanohalea (Parmeliaceae, Ascomycota): Insights on diversity, distributions, and a comparison of species tree and concatenated topologies, Mol. Phylogenet. Evol., 2013, 66, 138-152.
109. G. Singh, P. K. Divakar, F. Dal Grande, J. Otte, S. Parnmen, M. Wedin, A. Crespo, H. T. Lumbsch and I. Schmitt, The sister-group relationships of the largest family of lichenized fungi, Parmeliaceae (Lecanorales, Ascomycota), Fungal Biol., 2013, 117, 715-721.
110. N. Neamati, H. Hong, A. Mazumder, S. Wang, S. Sunder, M. C. Nicklaus, G. W. Milne, B. Proksa and Y. Pommier, Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching, J. Med. Chem., 1997, 40, 942-951.
111. R. Bandichhor, B. Nosse and O. Reiser, Paraconic Acids - The Natural Products from Lichen, Symbiont, 2005, 243, 43-72.
112. E. Stocker-Wörgötter, Metabolic diversity of lichen-forming ascomycetous fungi: culturing, polyketide and shikimate metabolite production, and PKS genes, Nat. Prod. Rep., 2008, 25, 188-200.
113. F. Odabasoglu, A. Aslan, A. Cakir, H. Suleyman, Y. Karagoz, Y. Bayir and M. Halici, Antioxidant activity, reducing power and total phenolic content of some lichen species, Fitoterapia, 2005, 76, 216-219.
114. H. Türkez, E. Aydin and A. Aslan, Role of aqueous Bryoria capillaris (Ach.) extract as a genoprotective agent on imazalil-induced genotoxicity in vitro, Toxicol. Ind. Health, 2014, 30, 33-39.
115. H. Zeytinoglu, Z. Incesu, B. A. Tuylu, A. O. Turk and B. Barutca, Determination of genotoxic, antigenotoxic and cytotoxic potential of the extract from lichen Cetraria aculeata (Schreb.) Fr. in vitro, Phytother. Res., 2008, 22, 118-123.
116. H. Luo, Y. Yamamoto, J. A. Kim, J. S. Jung, Y. J. Koh and J. Hur, Lecanoric acid, a secondary lichen substance with antioxidant properties from Umbilicaria antarctica in maritime Antarctica (King George Island), Polar. Biol., 2009, 32, 1033-1040.
117. T. O. Bakir, F. Geyikoglu, S. Colak, H. Türkez, A. Aslan and M. Bakir, The effects of Cetraria islandica and Pseudevernia furfuracea extracts in normal and diabetic rats, Toxicol. Ind. Health, 2013, DOI: 10.1177/0748233713475521.
118. M. Kosanić and B. Ranković, Antioxidant and antimicrobial properties of some lichens and their constituents, J. Med. Food, 2011, 14, 1624-1630.
119. S. Colak, F. Geyikoglu, A. Aslan and G. Y. Deniz, Effects of lichen extracts on haematological parameters of rats with experimental insulin-dependent diabetes mellitus, Toxicol. Ind. Health, 2012, DOI: 10.1177/0748233712466130.
120. K. Ingólfsdóttir, K. Jurcic and H. Wagner, Immunomodulating polysaccharides from aqueous extracts of Cetraria islandica (Iceland moss), Phytomedicine, 1998, 5, 333-339.
121. L. Alpsoy, F. Orhan, G. Nardemir, G. Agar, M. Gulluce and A. Aslan, Antigenotoxic potencies of a lichen species, Evernia prunastri, Toxicol. Ind. Health, 2013, DOI: 10.1177/0748233712469655.
122. J. G. Rowe, M. T. Saent and M. D. Garcia, Contribution à létude de lactivité antibactérienne de quelques lichens du sud de lEspagne, Ann. Pharm. Fr., 1989, 47, 89-94.
123. C. Bezivin, S. Tomasi, F. Lohezic-Le Devehat and J. Boustie, Cytotoxic activity of some lichen extracts on murine and human cancer cell lines, Phytomedicine, 2003, 10, 499-503.
124. B. Ranković, M. Misić and S. Sukdolak, Antimicrobial activity of extracts of the lichens Cladonia furcata, Parmelia caperata, Parmelia pertusa, Hypogymnia physodes and Umbilicaria polyphylla, Br. J. Biomed. Sci., 2007, 64, 143-148.
125. B. Ranković, M. Misić and S. Sukdolak, Antimicrobial activity of extracts of the lichens Cladonia furcata, Parmelia caperata, Parmelia pertusa, Hypogymnia physodes and Umbilicaria polyphylla, Biologia, 2009, 64, 53-58.
126. H. Türkez, E. Aydin and A. Aslan, Effects of Lichenic Extracts (Hypogymnia physodes, Ramalina polymorpha and Usnea florida) on Human Blood Cells: Cytogenetic and Biochemical Study, Iran. J. Pharm. Res., 2012, 11, 889-896.
127. M. Yilmaz, T. Tay, M. Kivanc¸, H. Türk and A. O. Türk, The antimicrobial activity of extracts of the lichen Hypogymnia tubulosa and its 3-hydroxyphysodic acid constituent, Z. Naturforsch., C: J. Biosci., 2005, 60, 35-38.
128. K. Hara, M. Endo, H. Kawakami, M. Komine and Y. Yamamoto, Anti-oxidation activity of ethanol extracts from natural thalli of lichens, Mycosystema, 2011, 30, 950-954.
129. M. R. Ren, J. S. Hur, J. Y. Kim, K. W. Park, S. C. Park, C. N. Seong, I. Y. Jeong, M. W. Byun, M. K. Lee and K. I. Seo, Anti-proliferative effects of Lethariella zahlbruckneri extracts in human HT-29 human colon cancer cells, Food Chem. Toxicol., 2009, 47, 2157-2162.
130. H. Luo, Y. Yamamoto, H. S. Jeon, Y. P. Liu, J. S. Jung, Y. J. Koh and J. S. Hur, Production of anti-Helicobacter pylori metabolite by the lichen-forming fungus Nephromopsis pallescens, J. Microbiol., 2011, 49, 66-70.
131. S. K. Shahi, M. Patra, A. Dikshit and D. K. Upreti, Parmelia cirrhatum: a potential source of broad spectrum natural antifungal, Phytother. Res., 2003, 17, 399-400.
132. C. O. Esimone, K. C. Ofokansi, M. U. Adikwu, E. C. Ibezim, D. O. Abonyi, G. N. Odaibo and D. O. Olaleye, In vitro evaluation of the antiviral activity of extracts from the lichen Parmelia perlata (L.) Ach. against three RNA viruses, J. Infect. Dev. Countries., 2007, 1, 315-320.
133. H. S. Rathore, Prevention of toxic effects of mercuric chloride on some male accessory organs in mice with a Multiherbal drug "SPEMAN", Ancient Sci. Life, 2000, 20, 6-10.
134. M. Goel, P. Dureja, A. Rani, P. L. Uniyal and H. Laatsch, Isolation, characterization and antifungal activity of major constituents of the Himalayan lichen Parmelia reticulata Tayl, J. Agric. Food Chem., 2011, 59, 2299-2307.
135. T. Özen and K. Kinalioglu, Determination of antioxidant activity of various extracts of Parmelia saxatilis, Biologia, 2008, 63, 211-216.
136. C. J. Johnson, J. P. Bennett, S. M. Biro, J. C. Duque-Velasquez, C. M. Rodriguez, R. A. Bessen and T. E. Rocke, Degradation of the disease-associated prion protein by a serine protease from lichens, PLoS One, 2011, 6, e19836.
137. M. Dharmadhikari, P. K. Jite and S. Chettiar, Antimicrobial activity of extracts of the lichen Parmelinella simplicior and its isolated mycobiont, Asian J. Exp. Biol. Sci., 2010, 54-58.
138. T. R. Kekuda, K. S. Vinayaka, S. V. Praveen Kumar and S. J. Sudharshan, Antioxidant and antibacterial activity of lichen extracts, honey and their combination, J. Pharm. Pract. Res., 2009, 2, 1875-1878.
139. P. Balaji and G. N. Hariharan, In vitro antimicrobial activity of Parmotrema praesorediosum thallus extracts, Res. J. Bot., 2007, 2, 54-59.
140. G. K. Jayaprakasha and L. J. Rao, Phenolic constituents from the lichen Parmotrema stuppeum (Nyl.) Hale and their antioxidant activity, Z. Naturforsch., C: J. Biosci., 2000, 55, 1018-1022.
141. I. K. Kusumaningrum, W. P. Suwarso and A. H. Cahyana, Screening for Bioactive Compound Group in Parmotrema tinctorum's Extract and Bioactivity Test of Dichloromethane extract as Anti-tuberculosis Against Mycobacterium tuberculosis H37RV and Toxicity Against Artemia salina, Sci. J. UBU, 2011, 2, 53-59.
142. G. Schmeda-Hirschmann, A. Tapia, B. Lima, M. Pertino, M. Sortino, S. Zacchino, A. R. Arias and G. E. Feresin, A new antifungal and antiprotozoal depside from the Andean lichen Protousnea poeppigii, Phytother. Res., 2008, 22, 349-355.
143. H. Türkez, F. Geyikoglu, A. Aslan, Y. Karagöz, O. Türkez and M. Anar, Antimutagenic effects of lichen Pseudovernia furfuracea (L.) Zopf, extracts against the mutagenicity of aflatoxin B1 in vitro, Toxicol. Ind. Health, 2010, 26, 625-631.
144. H. Türk, M. Yilmaz, T. Tay, A. O. Türk and M. Kivanc¸, Antimicrobial activity of extracts of chemical races of the lichen Pseudevernia furfuracea and their physodic acid, chloroatranorin, atranorin, and olivetoric acid constituents, Z. Naturforsch., C: J. Biosci., 2006, 61, 499-507.
145. I. T. Madamombe and A. J. Afolayan, Evaluation of Antimicrobial Activity of Extracts from South African Usnea barbata, Pharm. biol., 2003, 41, 199-202.
146. S. Weckesser, K. Engel, B. Simon-Haarhaus, A. Wittmer, K. Pelz and C. M. Schempp, Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance, Phytomedicine, 2007, 14, 508-516.
147. P. Vijayan, C. Raghu, G. Ashok, S. A. Dhanaraj and B. Suresh, Antiviral activity of medicinal plants of Nilgiris, Indian J. Med. Res., 2004, 120, 24-29.
148. E. C. Pereira, S. C. Nascimento, R. C. Lima, N. H. Silva, A. F. Oliveira, E. Bandeira, M. Boitard, H. Beriel, C. Vicente and M. E. Legaz, Analysis of Usnea fasciata crude extracts with antineoplastic activity, Tokai J. Exp. Clin. Med., 1994, 19, 47-52.
149. B. C. Behera, N. Verma, A. Sonone and U. Makhija, Determination of antioxidative potential of lichen Usnea ghattensis in vitro, LWT-Food Sci. Technol., 2006, 39, 80-85.
150. Y. Rukayadi, J. S. Shim and J. K. Hwang, Screening of Thai medicinal plants for anticandidal activity, Mycoses, 2008, 51, 308-312.
151. T. Tokiwano, H. Satoh, T. Obara, H. Hirota, Y. Yoshizawa and Y. Yamamoto, A Lichen Substance as an Antiproliferative Compound against HL-60 Human Leukemia Cells: 16-O-Acetyl-leucotylic acid isolated from Myelochroa aurulenta, Biosci. Biotechnol. Biochem., 2009, 73, 2525-2527.
152. S. R. Gollapudi, H. Telikepalli, H. B. Jampani, Y. W. Mirhom, S. D. Drake, K. R. Bhattiprolu, D. Vander Velde and L. A. Mitscher, Alectosarmentin, a new antimicrobial dibenzofuranoid lactol from the lichen, Alectoria sarmentosa, J. Nat. Prod., 1994, 57, 934-938.
153. D. Williams, K. Bombuwala, E. Lobkovsky, E. D. de Silva, V. Karunaratne, T. M. Alien, J. Clardy, R. J. Andersen, A. Ambewelamides and B. A. Epidithiapiperazinediones, Isolated from the Lichen Usnea sp, Tetrahedron Lett., 1998, 39, 9579-9582.
154. F. J. Toledo Marante, A. García Castellano, F. Estévez Rosas, J. Quintana Aguiar and J. Bermejo Barrera, Identification and quantitation of allelochemicals from the lichen Lethariella canariensis: phytotoxicity and antioxidative activity, J. Chem. Ecol., 2003, 29, 2049-2071.
155. N. K. Honda, F. R. Pavan, R. G. Coelho, S. R. de Andrade Leite, A. C. Micheletti, T. I. Lopes, M. Y. Misutsu, A. Beatriz, R. L. Brum and C. Q. Leite, Antimycobacterial activity of lichen substances, Phytomedicine, 2010, 17, 328-332.
156. K. C. Kumar and K. Müller, Lichen metabolites. 2. Antiproliferative and cytotoxic activity of gyrophoric, usnic, and diffractaic acid on human keratinocyte growth, J. Nat. Prod., 1999, 62, 821-823.
157. F. Odabasoglu, O. S. Yildirim, H. Aygun, Z. Halici, M. Halici, F. Erdogan, E. Cadirci, A. Cakir, Z. Okumus, B. Aksakal, A. Aslan, D. Unal and Y. Bayir, Diffractaic acid, a novel proapoptotic agent, induces with olive oil both apoptosis and antioxidative systems in Ti-implanted rabbits, Eur. J. Pharmacol., 2012, 674, 171-178.
158. A. Russo, S. Caggia, M. Piovano, J. Garbarino and V. Cardile, Effect of vicanicin and protolichesterinic acid on human prostate cancer cells: role of Hsp70 protein, Chem.-Biol. Interact., 2012, 195, 1-10.
159. F. Brisdelli, M. Perilli, D. Sellitri, M. Piovano, J. A. Garbarino, M. Nicoletti, A. Bozzi, G. Amicosante and G. Celenza, Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study, Phytother. Res., 2013, 27, 431-437.
160. B. Burlando, E. Ranzato, A. Volante, G. Appendino, F. Pollastro and L. Verotta, Antiproliferative effects on tumour cells and promotion of keratinocyte wound healing by different lichen compounds, Planta Med., 2009, 75, 607-613.
161. N. Sultana and A. J. Afolayan, A new depsidone and antibacterial activities of compounds from Usnea undulata Stirton, J. Asian Nat. Prod. Res., 2011, 13, 1158-1164.
162. T. Takeda, M. Funatsu, S. Shibata and F. Fukuoka, Polysaccharides of lichens and fungi. V. Antitumour active: polysaccharides of lichens of Evernia, Acroscyphus and Alectoria spp, Chem. Pharm. Bull., 1972, 20, 2445-2449.
163. E. S. Olafsdottir, K. Ingolfsdottir, H. Barsett, B. S. Paulsen, K. Jurcic and H. Wagner, Immunologically active (1 → 3)-(1 → 4)-alpha-D-glucan from Cetraria islandica, Phytomedicine, 1999, 6, 33-39.
164. T. Rezanka and K. Sigler, Hirtusneanoside, an unsymmetrical dimeric tetrahydroxanthone from the lichen Usnea hirta, J. Nat. Prod., 2007, 70, 1487-1491.
165. V. Pavlovic, I. Stojanovic, M. Jadranin, V. Vajs, I. Djordjević, A. Smelcerovic and G. Stojanovic, Effect of four lichen acids isolated from Hypogymnia physodes on viability of rat thymocytes, Food Chem. Toxicol., 2013, 51, 160-164.
166. Y. Nishikawa, K. Ohki, K. Takahashi, G. Kurono, F. Fukuoka and M. Emori, Studies on the water soluble constituents of Lichens. II. Antitumor Polysaccharides of Lasallia, Usnea and Cladonia species, Chem. Pharm. Bull., 1974, 22, 2692-2702.
167. D. Bogo, M. F. de Matos, N. K. Honda, E. C. Pontes, P. M. Oguma, E. C. da Santos, J. E. de Carvalho and A. Nomizo, In vitro antitumour activity of orsellinates, Z. Naturforsch., C: J. Biosci., 2010, 65, 43-48.
168. T. I. Lopes, R. G. Coelho, N. C. Yoshida and N. K. Honda, Radical-scavenging activity of orsellinates, Chem. Pharm. Bull., 2008, 56, 1551-1554.
169. A. A. Hunaiti, A. A. El-Oqlah and K. S. Abu-Gharibeh, A novel hemolysin from the lichen Parmelia pulla, Biochem. Int., 1988, 17, 1049-1058.
170. A. T. Koparal, G. Ulus, M. Zeytinoʇlu, T. Tay and A. O. Türk, Angiogenesis inhibition by a lichen compound olivetoric acid, Phytother. Res., 2010, 24, 754-758.
171. K. Ingólfsdóttir, G. A. Chung, V. G. Skúlason, S. R. Gissurarson and M. Vilhelmsdóttir, Antimycobacterial activity of lichen metabolites in vitro, Eur. J. Pharm. Sci., 1998, 6, 141-144.
172. T. Pengsuparp, L. Cai, H. Constant, H. H. Fong, L. Z. Lin, A. D. Kinghorn, J. M. Pezzuto, G. A. Cordell, K. Ingolfsdóttir, H. Wagner and S. H. Hughes, Mechanistic evaluation of new plant-derived compounds that inhibit HIV-1 reverse transcriptase, J. Nat. Prod., 1995, 58, 1024-1031.
173. H. M. Ogmundsdóttir, G. M. Zoëga, S. R. Gissurarson and K. Ingólfsdóttir, Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell-lines and mitogen-stimulated lymphocytes, J. Pharm. Pharmacol., 1998, 50, 107-115.
174. K. L. Moerman, C. L. Chai and P. Waring, Evidence that the lichen-derived scabrosin esters target mitochondrial ATP synthase in P388D1 cells, Toxicol. Appl. Pharmacol., 2003, 190, 232-240.
175. A. Fournet, M. E. Ferreira, A. Rojas de Arias, S. Torres de Ortiz, A. Inchausti, G. Yaluff, W. Quilhot, E. Fernandez and M. E. Hidalgo, Activity of compounds isolated from Chilean lichens against experimental cutaneous leishmaniasis, Comp. Biochem. Physiol., Part C: Pharmacol., Toxicol. Endocrinol., 1997, 116, 51-54.
176. B. Safak, I. H. Ciftci, M. Ozdemir, N. Kiyildi, Z. Cetinkaya, O. C. Aktepe, M. Altindis and G. Asik, In vitro anti-Helicobacter pylori activity of usnic acid, Phytother. Res., 2009, 23, 955-957.
177. C. Kohlhardt-Floehr, F. Boehm, S. Troppens, J. Lademann and T. G. Truscott, Prooxidant and antioxidant behaviour of usnic acid from lichens under UVB-light irradiation-studies on human cells, J. Photochem. Photobiol., B, 2010, 101, 97-102.
178. E. Einarsdóttir, J. Groeneweg, G. G. Björnsdóttir, G. Harethardottir, S. Omarsdóttir, K. Ingólfsdóttir and H. M. Ogmundsdóttir, Cellular mechanisms of the anticancer effects of the lichen compound usnic acid, Planta Med., 2010, 76, 969-974.